InvestorsHub Logo

loanranger

08/22/15 4:34 PM

#114564 RE: changes_iv #114563

"The study was conducted by KARD Scientific, Inc. Dr. Krishna Menon, President of KARD and consulting Regulatory Officer for NanoViricides, Inc., has advised the Company that some of the orally administered drug candidates provided by NanoViricides showed efficacy in combatting highly lethal influenza H1N1 infection in mice."

Uncle Kirishna says it works great!